|
|
english
|
español
|
français
|
Sign Up for an Account
|
Sign In
Country Profiles...
Home
The BCH
The Protocol
Finding Information
Registering Information
Resources
Help
Finding Information
National Contacts
Laws and Regulations
Country's Decisions and other Communications
Submissions
Risk Assessments
Roster of Experts
LMOs, Genes or Organisms
National Reports
Capacity-Building
Organizations
The BCH Virtual Library
Survey on indicators (2014)
Compiled Information
National Contacts
LMO Registry
Organism Registry
Gene Registry
Go to record ID
Home
|
Finding Information
|
Record details
Risk Assessment
Record information and status
Record ID
115659
Status
Published
Date of creation
2020-06-16 10:11 UTC (jnjagi@biosafetykenya.go.ke)
Date of publication
2020-07-21 11:31 UTC (mutui@biosafetykenya.go.ke)
Tweeter
General Information
Country
Kenya
Title of risk assessment
Summary risk assessment report on the application for Confined Field Trial of a novel Rift Valley Fever Vaccine in sheep, goats, cattle and camels
Date of the risk assessment
2016-11-25
Competent National Authority(ies) responsible for the risk assessment
Record #8339
National Biosafety Authority
Pest Control Products Board (PCPB) Building, Loresho, off Waiyaki Way
Nairobi, Nairobi
Kenya, 28251--00100
Phone:
(+254) (20) (2678667)
Email:
info@biosafetykenya.go.ke
Url:
National Biosafety Office - Kenya
Risk assessment details
Living modified organism
Record #115616
Rift Valley Fever Virus DIVA vaccine
Dr. George Warimwe Production of medical or pharmaceutical compounds (human or animal) - Vaccines, Antibodies and antigens
Scope of the risk assessment
LMOs for Introduction into the environment
Field trial
Risk assessment report / Summary
Risk assessment summary for RFV Vaccine.pdf
Contact us
|
Site Map
|
Linkages Policy
|
Privacy Policy
|
Disclaimer
|
© SCBD 2001-2016
Rate this page
- 65 people have rated this page